Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating CUDR , LSINCT ‐5 and PTENP 1 long noncoding RNA s in sera distinguish patients with gastric cancer from healthy controls

18 Feb 2015

Abstract excerpt

The examination of circulating nucleic acids (CNAs) is an emerging noninvasive diagnostic technique. However, it is unclear if serum long noncoding RNAs (lncRNAs) represent a novel marker to detect gastric cancer (GC). In this study, we measured 39 candidate cancer-associated lncRNAs by reverse transcription and quantitative polymerase chain reaction (RT-qPCR) in sera from 110 patients with GC, 106 age- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25694351
DOI: 10.1002/ijc.29484

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating CUDR , LSINCT ‐5 and PTENP 1 long noncoding RNA s in sera distinguish patients with gastric cancer from healthy controlsPMID 25694351Read ↗

A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?Semantic proximity Read ↗

Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric CancerSemantic proximity Read ↗

Long noncoding RNAs in gastric cancer: From molecular dissection to clinical applicationSemantic proximity Read ↗

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistanceSemantic proximity Read ↗

Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.Semantic proximity Read ↗

Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studiesSemantic proximity Read ↗

Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implicationsSemantic proximity Read ↗

Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosisSemantic proximity Read ↗

Circulating Exosomal Gastric Cancer–Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric CancerSemantic proximity Read ↗

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancerSemantic proximity Read ↗

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics.Semantic proximity Read ↗

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.